S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
S&P 500   3,998.84
DOW   33,947.10
QQQ   287.64
All the Cloud Storage You Need Is on Sale for the Holidays
Why is Russia reopening dormant copper mines? (Ad)
Tesla Shares Are Sliding, Here’s Why
Is Big Lots the Next Bed Bath & Beyond Disaster in the Making?
China Threat Triggers Potential Mining Boom for Investors (Ad)
Lockheed teams with Israel's Rafael on laser defense
Russian oil price cap, EU ban aim to limit Kremlin war chest
Why is Russia reopening dormant copper mines? (Ad)
World Cup fans find booze at hotels, Qatar's 1 liquor store
3 Signs the Stock Market Outlook is Improving
LON:DDDD

4D pharma - DDDD Share Forecast, Price & News

GBX 16.66
0.00 (0.00%)
(As of 11/8/2022)
Add
Compare
Today's Range
16.66
16.66
50-Day Range
16.66
16.66
52-Week Range
16.66
16.66
Volume
1.21 million shs
Average Volume
2.96 million shs
Market Capitalization
£30.04 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
DDDD stock logo

About 4D pharma (LON:DDDD) Stock

4D pharma plc, together with its subsidiaries, develops live biotherapeutic products (LBPs) in the United Kingdom. The company develops therapeutic candidates, including MRx0518 for the treatment of cancer and immune-oncology diseases; MRx-4DP0004 for the treatment of asthma; MRx0029 and MRx0005 the treatment of central nervous system disorders; Blautix for irritable bowel syndrome; and Thetanix for pediatric crohn's disease. It also develops products candidates, such as MRx1299 for solid tumors, MRx0006 for rheumatoid arthritis, and MRx0002 for multiple sclerosis. In addition, the company develops MicroRx platform to discover new LBP candidates for major diseases. 4D pharma plc has a collaboration agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate MRx0518; strategic collaboration agreement with University of Texas MD Anderson for discovery and development of LBPs in oncology; and Merck & Co., Inc. to conduct a clinical trial evaluating the combination of Keytruda, MRx0518 in patients with solid tumors, and to discover and develop LBPs for vaccines. The company was formerly known as Schosween 18 Limited. 4D pharma plc was incorporated in 2014 and is headquartered in Leeds, the United Kingdom.

Receive DDDD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4D pharma and its competitors with MarketBeat's FREE daily newsletter.

DDDD Stock News Headlines

4D pharma plc (DDDD.L)
Update on Suspension of Trading
4D Pharma PLC soars after meeting endpoint early
4D Pharma soars after meeting endpoint early
4D pharma prepares the ground for potential US fundraiser
How Much Of 4D pharma plc (LON:DDDD) Do Insiders Own?
See More Headlines
Receive DDDD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4D pharma and its competitors with MarketBeat's FREE daily newsletter.

DDDD Company Calendar

Last Earnings
9/30/2020
Today
12/05/2022

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
106
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£718,000.00
Cash Flow
GBX 11.60 per share
Book Value
GBX 18 per share

Miscellaneous

Free Float
N/A
Market Cap
£30.04 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Duncan Joseph Peyton (Age 52)
    CEO & Exec. Director
    Comp: $254k
  • Dr. Alexander James Stevenson Ph.D. (Age 50)
    Chief Scientific Officer & Exec. Director
    Comp: $218k
  • Mr. John Brendan Doyle (Age 44)
    Chief Financial Officer
  • Ms. Fay Weston
    Head of Investor Relations
  • Mr. Adrian Murray
    Gen. Counsel (Interim)
  • Mr. Glenn Dourado
    Exec. VP of Corp. Devel.
  • Ms. Lucy Christie
    VP of HR
  • Mr. Christophe Carite
    Sr. VP of CMC & Process Devel.
  • Ms. Imke Mulder
    Exec. VP of Research













DDDD Stock - Frequently Asked Questions

How were 4D pharma's earnings last quarter?

4D pharma plc (LON:DDDD) announced its quarterly earnings results on Wednesday, September, 30th. The company reported ($14.06) earnings per share for the quarter.

What other stocks do shareholders of 4D pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other 4D pharma investors own include Amigo (AMGO), Adamis Pharmaceuticals (ADMP), American Airlines Group (AAL), Boeing (BA), Cineworld Group (CINE), Cray (CRAY), Omega Diagnostics Group (ODX), Oracle (ORCL), Senseonics (SENS) and Tullow Oil (TLW).

What is 4D pharma's stock symbol?

4D pharma trades on the London Stock Exchange (LON) under the ticker symbol "DDDD."

How do I buy shares of 4D pharma?

Shares of DDDD stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

How much money does 4D pharma make?

4D pharma (LON:DDDD) has a market capitalization of £0.00 and generates £718,000.00 in revenue each year.

How many employees does 4D pharma have?

The company employs 106 workers across the globe.

How can I contact 4D pharma?

4D pharma's mailing address is 9 Bond Court, LEEDS, LS1 2JZ, United Kingdom. The official website for the company is www.4dpharmaplc.com. The company can be reached via phone at +44-113-8950130.

This page (LON:DDDD) was last updated on 12/6/2022 by MarketBeat.com Staff